Airsonett TLA has extensive clinical documentation and is reviewed and recommended by several medical agencies. Please contact us to download further literature or to book a meeting.
reviews the guidelines and still recommends TLA as an add-on treatment for Asthma
Renewed recommendation
Also recommended for Atopic Dermatitis: “Treatment with Airsonett can be particularly valuable in the combination of severe asthma and severe eczema, as the treatment affects both conditions favourably.”
recommends TLA for “patients with verified perennial airway allergy and uncontrolled asthma despite drug treatment step 4”
Add-on treatment asthma (MPO)
considers treatment with TLA to be cost-effective given the data available, provided that the patient corresponds to the indication.
“Treatment with Airsonett can be particularly valuable in the combination of severe asthma and severe eczema, as the treatment affects both conditions favourably.”